- Home
- RSLS vs UOKA Comparison
RSLS vs UOKA Comparison
Compare RSLS & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- UOKA
- Stock Information
- Founded
- RSLS 2002
- UOKA 2002
- Country
- RSLS United States
- UOKA United Kingdom
- Employees
- RSLS N/A
- UOKA N/A
- Industry
- RSLS Medical/Dental Instruments
- UOKA
- Sector
- RSLS Health Care
- UOKA
- Exchange
- RSLS Nasdaq
- UOKA NYSE
- Market Cap
- RSLS 3.2M
- UOKA 2.6M
- IPO Year
- RSLS 2007
- UOKA N/A
- Fundamental
- Price
- RSLS $0.64
- UOKA $0.16
- Analyst Decision
- RSLS Hold
- UOKA
- Analyst Count
- RSLS 1
- UOKA 0
- Target Price
- RSLS N/A
- UOKA N/A
- AVG Volume (30 Days)
- RSLS 3.3M
- UOKA 17.8M
- Earning Date
- RSLS 05-14-2025
- UOKA 03-25-2025
- Dividend Yield
- RSLS N/A
- UOKA N/A
- EPS Growth
- RSLS N/A
- UOKA N/A
- EPS
- RSLS N/A
- UOKA N/A
- Revenue
- RSLS $8,183,000.00
- UOKA $114,849.00
- Revenue This Year
- RSLS $17.47
- UOKA N/A
- Revenue Next Year
- RSLS $20.00
- UOKA N/A
- P/E Ratio
- RSLS N/A
- UOKA N/A
- Revenue Growth
- RSLS N/A
- UOKA 289.97
- 52 Week Low
- RSLS $0.61
- UOKA $0.13
- 52 Week High
- RSLS $29.00
- UOKA $0.45
- Technical
- Relative Strength Index (RSI)
- RSLS 19.62
- UOKA N/A
- Support Level
- RSLS $0.63
- UOKA N/A
- Resistance Level
- RSLS $1.28
- UOKA N/A
- Average True Range (ATR)
- RSLS 0.12
- UOKA 0.00
- MACD
- RSLS 0.06
- UOKA 0.00
- Stochastic Oscillator
- RSLS 3.31
- UOKA 0.00
Stock Price Comparison Chart: RSLS vs UOKA
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.